The inflammatory response is primarily a host defence reaction. It serves to degrade and eliminate the foreign invader. Components of the inflammatory response play essential roles when phagocytic cells remove microorganisms, necrotic host tissue and undesired deposits of abnormal substance. However, prolonged inflammation often destroys the surrounding host tissue. Such a damage is particularly serious if it occurs in brain, where regeneration and recovery take place only in a very limited degree. Alzheimer's disease (AD) is characterized pathologically by heavy accumulation of /3-amyloid and neurofibrillary tangles. This indicates the failure or, at best, partial success of the removal of these unpleasant deposits. Senile plaques and ghost tangles could, therefore, be the site of sustained inflammatory response.
In the periphery, the process of inflammatory response is consistent regardless of the inciting agent. Following the activation of several plasma proteins such as the contact activation, complement and coagulation systems, phagocytic cells 
Microglia as inflammatory cells in brain
In brain, the key cell in the inflammatory processes is the reactive microglial cell. In 1919, del Rio Hortega described the third element, "el tercer elemento", that had puzzled Ramon y Cajal. With his new silver carbonate stain, he divided "el tercer elemento" into two cell types (del Rio Ho rtega 1919). One is oligodendroglia, the myelin forming cells of neuroectodermal origin. The other is microglia, which he believed to be phagocytic in nature and of mesodermal origin. Fig. lA-C illustrate morphology of microglial cells at different stages of activation from `resting' microglia (A) to brain macrophages (C) (Penfield 1925) . Since the first description by del Rio Hortega, the origin and the nature of brain microglia have long been a matter of significant debate (Jordan and Thomas 1988 
Expression of f32-integrins and their ligands
Another important instrument for the immune cells is the cell adhesion molecules. j32-integrin is a family of cell adhesion molecules that are expressed by cells of leukocyte lineage. So far, three molecules have been identified; leucocyte function associated antigen (LFA)-1, CR3 (Mac-1), and CR4 (p150,95). All members of f32-integrin appear to play significant roles in the pathological processes of Alzheimer's disease ). In the cerebral cortex of normal subjects, resting microglia are stained weakly for LFA-1. In . A major ligand for LFA-1 is ICAM-1, a cell adhesion molecule which belongs to the immunoglobulin gene superfamily. In Alzheimer brain, senile plaque amyloid is stained intensely for ICAM-l. In addition, fine fibrous structures extend beyond such amyloid deposits (Fig. 2C ) (Akiyama et al. 1993a ). Double immunostaining for GFAP and ICAM-1 has revealed that reactive astrocytes marginating senile plaques express ICAM-l. Thus, in brain, reactive microglia and astrocytes seem to communicate via the LFA-1 and ICAM-1 mediated cell-cell adhesion.
Other members of R2-integrin are complement receptors CR3 (Mac-1) and CR4. Both CR3 and CR4 are constitutively expressed by microglia . In Alzheimer's disease, the expression of CR3 and CR4 is again upregulated. The major ligands for CR3 and CR4 are complement fragments generated by the activation of complement C3. Complement activation takes place through sequential cascade-like activation of serine processes. During the activation processes, cleaved fragments of complement proteins such as C3a and C5a, called anaphylatoxins, mediate features of the inflammatory response. Some other fragments mediate the process of opsonization, in which foreign particles are prepared to be phagocytosed through recognition by receptors for these opsonins on phagocytic cells. Complement proteins of the classic activation pathway have been detected in lesions of Alzheimer's disease ). Fig. 3A shows the staining of AD cortex for C4d, a post-activation fregment of C4. The /3-amyloid deposits and extracellular neurofibrillary tangles are stained postively. In double immunostaining for C4d and HLA-DR, HLA-DR positive reactive microglia aggregate around the /3-amyloid deposits (Fig 3B) and extracellular ghost tangles (Fig. 3C ). These pathological debris appear to be opsonized by complements so that they are phagocytosed by activated microglial cells which vigorously express the complement receptors. CR3 (Mac-1) also mediates microglial activation, suggesting multiple roles of the complement system in brain lesions (Akiyama et al. 1994a ).
Coagulation system
There is evidence for an involvement of other humoral elements of the inflammatory process in Alzheimer lesions. The blood coagulation system was discovered originally as a mechanism to control bleeding at the site of vascular injury. However, it is also an important component of the immune and inflammatory reaction. Interestingly, at an earlier stage of evolution, a common ancestor of complement and coagulation proteins is known to form a more general defence system protecting the organism from infection and tissue injury. Central to coagulation is the generation of thrombin from its enzymatically inactive precursor, prothrombin. This highly active serine protease has multiple biological activities on a variety of cells. Thrombin causes rapid neurite retraction of cultured neurons. Cultured astrocytes become round and start proliferation after thrombin stimulation. Thrombin works as chemoattractant and mitogen for monocytes and macrophages, and, perhaps, for microglia. In in vitro studies, thrombin has been reported to upregulate the synthesis of /3-amyloid precursor protein (APP) by platelets and to cleave APP to generate a fragment which contains the /3-amyloid protein sequence. Fig. 4 illustrates immunohistochemical localization of thrombin in Alzheimer brain. Residual blood plasma in the vessels and senile plaque /-amyloid are stained positively (Fig. 4A) . The immunostaining for thrombin is completely abolished by absorption of the primary antibody with purified thrombin but not with its proenzyme, prothrombin (Akiyama et al. 1992) . Thrombin is also present in diffuse /3-amyloid protein deposits and extracellular ghost tangles (Fig. 4B) . These results are consistent with a report by Wagner et al. (1989) showing the reduction of protease nexin (PN)-1 in Alzheimer brain. PN-1 is a potent inhibitor of thrombin and extremely rich in brain.
Complement activated oligodendroglia was first reported by Yamada et al. in 1990. These complement-coated oligodendroglia occur in many degenerative neurological diseases. These oligodendroglia are considered to be under a degenerative process being opsonized by complements for removal. Complement activated oligodendroglia are stained positively for thrombin. Co-localization of thrombin and complement proteins in a variety of brain lesions suggests an interaction between these systems. This is an issue to be addressed in future studies, however. In a classic scheme of the blood coagulation system, two activation pathways are known. One is the intrinsic pathway which starts from the contact activation system. The other is the extrinsic pathway which is initiated by an exposure of the membrane protein `tissue factor' to the extracellular milieu. The key step in the cascade is the cleavage of prothrombin to generate thrombin by a complex of activated factor V and factor X. This complex is called prothrombinase complex, in which activated factor X (FXa) is an active protease and factor Va, being embedded in the phospholipid membrane, serves as a receptor for FXa. In the periphery, macrophages as well as platelets are known to provide phospholipid membrane surface where the prothrombinase complex is formed. It has yet to be determined whether reactive microglia carry the active prothrombinase complex on their surface or not. Tissue factor, an initiator of the extrinsic coagulation cascade has been shown to be concentrated in senile plaques (McComb et al. 1991) . FX is also detected immunohistochemically in senile plaques. An antibody to FV stains granular structures within senile plaques. These granules appear to be located in microglia. Such results suggest that, in brain, thrombin is generated via the classic extrinsic pathway. However, an alternative mechanism for the factor X activation may exist. As previously mentioned, microglia constitutively express CR3 (Mac-1), a member of N2-integrin. Evidence is available indicating that CR3 is bound to factor X and activates it in the absence of factor V. There might be multiple pathways for the activation of factor X on microglial cell surface.
Fibrinolysis system
Physiological and pathological roles of the extravascular fibrinolysis are now issues of extensive investigations in many organs. As a member of the mononuclear phagocyte system, microglia are supposed to regulate plasminogen activator (PA) and plasmin activity on their cell surface. Cultured microglia from fetal rat brain have been shown to secrete urokinase type-PA. Microglia in postmortem human brain tissue are immunostained for urokinase type plasminogen activator. Microglia are also positive for type-2 plasminogen activator inhibitor (PAI-2) (Akiyama et al. 1993b ). Again, the expression of these molecules are upregulated by reactive microglia located in senile plaques.
Conclusion
In summary, senile plaques are comparable in many respect with a site of persistent inflammation. Reactive microglia, a brain representative of the mononuclear phagocyte system, agglomerate in the centre of f3-amyloid deposits. Astrocytes interact with microglia and demarcate these inflammatory loci. Both the complement and coagulation cascades are activated to cooperate with these cellular elements. Proteases which belong to the fibrinolysis system appear to play a role in microglial function. These proteins were originally discovered in plasma. However, the majority are now known to be synthesized and secreted by activated macrophages. Furthermore, in vitro studies have indicated that some of these proteins are produced by microglia, astrocytes or neurons. Activation of these systems, therefore, could take place without the breakdown of the bloodbrain barrier. Detection of the components of these major self defence mechanisms, both humoral and cellular, supports a notion that inflammatory processes are involved in Alzheimer lesions. Formation of dystrophic neurites in senile plaques, and the deposition of /l-amyloid in ghost tangles might be a sequence of such persistent inflammatory responses in Alzheimer brain.
